Desvancosaminyl vancomycin

Star0

DB04529ExperimentalSmall molecule

Desvancosaminyl vancomycin: Overview.

Formula / weight: C₅₉H₆₂Cl₂N₈O₂₂ · 1306.08 g/mol (avg)
Also known as: Pseudovancomycin · Vancomycin pseudoaglycone

Resolves to

Compound

UNII43WYS9K792CAS101485-50-1ChEBI75953PubChem71768141

Structure

InChIKeyQCHYVJAUGVHJHX-PZIRYZLHSA-NSMILES

CN[C@H](CC(C)C)C(=O)N[C@@H]1[C@H](O)C2=CC=C(OC3=C(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C4=CC(=C3)[C@@H](NC(=O)[C@H](CC(N)=O)NC1=O)C(=O)N[C@@H]1C3=CC(=C(O)C=C3)C3=C(O)C=C(O)C=C3[C@H](NC(=O)[C@@H](NC1=O)[C@H](O)C1=CC(Cl)=C(O4)C=C1)C(O)=O)C(Cl)=C2

Targets

Q9AFC7gtfDP96558gtfA

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

Which drugs share a target with Desvancosaminyl vancomycin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account